Celldex Therapeutics, Inc. (NASDAQ:CLDX) Stock Has Average Price Target of $61.92 According to Analysts
MarketBeat
Celldex Therapeutics, Inc. (NASDAQ:CLDX - Get Free Report) has been given an average recommendation of "Moderate Buy" by the fourteen analysts that are covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, el
NASDAQ:CLDX